Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L McCall

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Pharmacology|December 18, 2017
Using Controlled Substance Receipt Patterns to Predict Prescription Overdose DeathChristina T Holt, Kenneth L McCall, Gary Cattabriga, et al.
The Senior Care Pharmacist|June 28, 2024
Utilization of Lower-Dose Cyclobenzaprine in the Older InpatientKatherine G Coli, Jaylan M Yuksel, Kenneth L McCall, et al.
International Journal of Clinical Pharmacy|February 5, 2024
First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance databaseKenneth L McCall, Bennett J Doughty, Brian J Piper, et al.
Pharmacy (Basel, Switzerland)|January 22, 2024
Declining but Pronounced State-Level Disparities in Prescription Opioid Distribution in the United StatesJoshua D Madera, Amanda E Ruffino, Adriana Feliz, et al.
Pharmacopsychiatry|February 23, 2021
Opioid Mortality Following Implementation of Medical Cannabis Programs in the United StatesDaniel E Kaufman, Asawer M Nihal, Janan D Leppo, et al.
HIV Medicine|September 5, 2024
Therapeutic failure reported with HIV long-acting injectables: An analysis of the FDA Adverse Event Reporting System from 2021 to 2024Kenneth L McCall, Danielle L Cabral, Jamie F Coghlan, et al.
Peerj|January 17, 2022
Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United StatesSneha M Vaddadi, Nicholas J Czelatka, Belsy D Gutierrez, et al.
Clinical Drug Investigation|May 15, 2023
Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) DatabaseEmily E Leppien, Bennett J Doughty, Karyssa L Hurd, et al.
Pharmacy (Basel, Switzerland)|July 25, 2024
Dynamic Changes in the Distribution of Hydrocodone and Oxycodone in Florida from 2006 to 2021Elena Lynn Stains, Akshay C Patel, Jay P Solgama, et al.
Schizophrenia Research|March 25, 2023
Thirteen-fold variation between states in clozapine prescriptions to United States Medicaid patientsRizelyn A Benito, Michael H Gatusky, Mariah W Panoussi, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Pharmacology|December 18, 2017
Using Controlled Substance Receipt Patterns to Predict Prescription Overdose DeathChristina T Holt, Kenneth L McCall, Gary Cattabriga, et al.
The Senior Care Pharmacist|June 28, 2024
Utilization of Lower-Dose Cyclobenzaprine in the Older InpatientKatherine G Coli, Jaylan M Yuksel, Kenneth L McCall, et al.
International Journal of Clinical Pharmacy|February 5, 2024
First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance databaseKenneth L McCall, Bennett J Doughty, Brian J Piper, et al.
Pharmacy (Basel, Switzerland)|January 22, 2024
Declining but Pronounced State-Level Disparities in Prescription Opioid Distribution in the United StatesJoshua D Madera, Amanda E Ruffino, Adriana Feliz, et al.
Pharmacopsychiatry|February 23, 2021
Opioid Mortality Following Implementation of Medical Cannabis Programs in the United StatesDaniel E Kaufman, Asawer M Nihal, Janan D Leppo, et al.
HIV Medicine|September 5, 2024
Therapeutic failure reported with HIV long-acting injectables: An analysis of the FDA Adverse Event Reporting System from 2021 to 2024Kenneth L McCall, Danielle L Cabral, Jamie F Coghlan, et al.
Peerj|January 17, 2022
Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United StatesSneha M Vaddadi, Nicholas J Czelatka, Belsy D Gutierrez, et al.
Clinical Drug Investigation|May 15, 2023
Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) DatabaseEmily E Leppien, Bennett J Doughty, Karyssa L Hurd, et al.
Pharmacy (Basel, Switzerland)|July 25, 2024
Dynamic Changes in the Distribution of Hydrocodone and Oxycodone in Florida from 2006 to 2021Elena Lynn Stains, Akshay C Patel, Jay P Solgama, et al.
Schizophrenia Research|March 25, 2023
Thirteen-fold variation between states in clozapine prescriptions to United States Medicaid patientsRizelyn A Benito, Michael H Gatusky, Mariah W Panoussi, et al.
Pageof 7